Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Tonix Pharmaceuticals Holding Corp. (TNXP) had Return on Equity of -9.33% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.43M |
|
$-16.83M |
|
$0.94M |
|
$1.49M |
|
$18.48M |
|
$-16.05M |
|
$-0.78M |
|
$-16.83M |
|
$-16.83M |
|
$-16.83M |
|
$-16.83M |
|
$-16.83M |
|
$-16.83M |
|
$-16.05M |
|
$-15.50M |
|
5.93M |
|
5.93M |
|
$-2.84 |
|
$-2.84 |
|
| Balance Sheet Financials | |
$149.57M |
|
$41.77M |
|
$43.30M |
|
$192.87M |
|
$12.15M |
|
-- |
|
$0.33M |
|
$12.47M |
|
$180.40M |
|
$180.28M |
|
$180.40M |
|
6.88M |
|
| Cash Flow Statement Financials | |
$-16.58M |
|
$-0.01M |
|
$49.53M |
|
$99.68M |
|
$132.62M |
|
$32.94M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
61.18% |
|
-660.93% |
|
-660.93% |
|
-- |
|
-692.84% |
|
-692.84% |
|
$-16.59M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.12 |
|
0.73 |
|
122.72 |
|
|
Return on Equity |
-9.33% |
-9.34% |
|
-8.73% |
|
-9.33% |
|
$26.23 |
|
$-2.80 |
|
$-2.80 |
|